trending Market Intelligence /marketintelligence/en/news-insights/trending/Grq3zVYQISEabL8QxMl7zw2 content esgSubNav
In This List

Kindred Biosciences plans common stock offering

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Kindred Biosciences plans common stock offering

Kindred Biosciences Inc. is looking to raise funds for its product pipeline via an underwritten public offering that is yet to be priced.

The San Francisco-based biotechnology company, which is developing medicines for pets, has engaged Barclays Capital Inc. and Stifel as joint book-running managers. The underwriters will have an option to buy additional shares from the company.